Authors
Shevchenko Yu.L., Borshchev G.G., Vahromeeva M.N., Vahrameeva A.Yu., Ulbashev D.S., Ermakov D.Yu.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Coronary heart disease is currently one of the main causes of mortality, temporary and permanent disability of the population in the developed countries of the world. The problem of treating such patients is currently aggravated by an increase in cases of detection of diffuse lesions of the coronary bed, when the usual tactics of complete direct revascularization becomes impossible. In this regard, the attention of cardiac surgeons is directed to the development of new treatment methods. In such conditions, the issue of preoperative diagnosis of the viable myocardium becomes especially relevant, which can significantly affect the choice of surgery tactics aimed at the complete restoration of myocardial perfusion of the left ventricle.
Keywords: coronary heart disease, revascularization, viable myocardium, hibernation, stanning, gated SPECT.
References
1. Bokeria LA, Milievskaya EB, Pryanishnikov VV, Yurlov IA. Cardiovascular surgery — 2022. Diseases and congenital anomalies of the circulatory system. Moscow: NMIC SSH named after A.N.Bakulev; 2023. (In Russ.)
2. Tolpygina SN, Martsevich SIu. Investigation of CHD PROGNOSIS: New long-term follow-up data. Profilakticheskaya Meditsina. 2016; 19(1): 30‑36. (In Russ.) doi: 10.17116/profmed201619130-36.
3. Shlyakhto EV. Cardiology : a national guide. 2nd ed., reprint. and an additional one. Moscow: GEOTAR-Media, 2021. (In Russ.)
4. Drapkina OM, Samorodskaya IV. Dynamics of regional mortality rates from heart disease in Russia in 2019-2021. Preventive medicine. 2022; 25(12): 64‑70. (In Russ.) doi: 10.17116/profmed20222512164.
5. Shevchenko YL, Borshchev GG. Extracardial myocardial revascularization in patients with coronary artery disease with diffuse coronary lesion. — M.: National Medical and Surgical Center named after N.I.Pirogov, 2022. (In Russ.)
6. Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2022; 145(11): e771]. Circulation. 2022; 145(3): e4-e17. doi: 10.1161/CIR.0000000000001039.
7. Bangalore S, Toklu B, Patel N, Feit F, Stone GW. Newer-generation ultrathin strut drugeluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease. Circulation. 2018; 138: 2216-26.
8. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010; 122(10): 949-57.
9. Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, et al. ISCHEMIA Research Group. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol. 2019; 4(3): 273-286.
10. Spertus J, Mark D. ISCHEMIA trial update. Am Heart J. 2019; 218: 8.
11. Bokeria LA, Vakhromeeva MN, Aslanidi IP, et al. The possibilities of nuclear diagnostic methods in the differentiation of viable myocardium in patients with coronary heart disease who are planning to undergo transmyocardial laser revascularization. Bulletin of the A.N.Bakulev National Agricultural Research Center of the Russian Academy of Sciences. 2004; 4: 13-24. (In Russ.)
12. Bokeria LA, Georgiev GP, Golukhova EZ, et al. The possibilities of using gene and cellular technologies for the treatment of cardiovascular diseases. Bulletin of the National Academy of Sciences named after A.N.Bakulev of the Russian Academy of Sciences. 2004; 5(3): 19-38. (In Russ.)
13. Bokeria LA, Golukhova EZ, Eremeeva MV, et al. The first clinical experience of therapeutic angiogenesis using the human VEGF165 gene. Bulletin of the National Academy of Sciences named after A.N.Bakulev of the Russian Academy of Sciences. 2004; 5(4): 134-142. (In Russ.)
14. Shevchenko YL, Berezovets IG, Popov LV. Myocardial revascularization on a working heart in patients with combined pathology. Bulletin of the National Academy of Sciences named after A.N. Bakulev of the Russian Academy of Sciences. 2008; 4(3): 105. (In Russ.)
15. Shevchenko YL, Borisov IA, Viller AG, et al. Possibilities of endovascular technologies in restoring myocardial blood supply in patients with coronary artery disease with chronic occlusion of the coronary arteries and recurrence of angina pectoris after CABG. Bulletin of the National Academy of Sciences named after A.N. Bakulev of the Russian Academy of Sciences. 2003; 4(11): 223. (In Russ.)
16. Krnchoyan AV, Lyashenko SA, Starovojtenko AG, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting in patients with severe forms of ischemic heart disease. Endoscopic Surgery. 2018; 24(5): 39‑44. (In Russ.) doi: 10.17116/endoskop20182405139.
17. Troitskiy AV, Zotov AS, Tereshchenko VI, et al. Immediate results of surgical treatment of coronary artery disease in patients with diffuse coronary lesion. Annals of Surgery. 2018; 23(3): 159-166. (In Russ.) doi: 0.18821/1560-9502-2018-23-3-159-166.
18. Akchurin RS, Shiryaev AA, Andreev AV, et al. Coronary bypass surgery in diffuse coronary artery disease: the use of autoarterial transplants. Cardiological Bulletin. 2021; 16(4): 5-10. (In Russ.)
19. Bokeria LA, Berishvili II, Sigaev IY. Myocardial revascularization: changing approaches and ways of development. Thoracic and cardiovascular surgery. 1999; 6: 102-112. (In Russ.)
20. Bokeria LA, Pyat YuV, Batyraliev TA, Pershukov IV, et al. Determination of preoperative and intraoperative predictors of the effectiveness of surgical myocardial revascularization in diffuse lesions of the anterior interventricular branch. Bulletin of the A.N. Bakulev National Agricultural Research Center of the Russian Academy of Sciences. 2002; 3(7): 20-26. (In Russ.)
21. Bokeria LA, Pyat YuV., Batyraliev TA, Pershukov IV, et al. Surgical revascularization of the myocardium with diffuse lesion of the anterior interventricular branch. Thoracic and cardiovascular surgery. 2002; 3: 43-46. (In Russ.)
22. Zhbanov IV, Shabalkin BV. Long-term results of repeated coronary artery bypass grafting. Thoracic and cardiovascular surgery. 2000; 1: 35-37. (In Russ.)
23. Knyshev GV, Furkalo SN, et al. The possibilities of prognostic assessment of the condition of coronary artery grafts and the dynamics of changes in the coronary artery in patients with coronary artery disease after coronary artery bypass grafting. Thoracic and cardiovascular surgery. 1994; 2: 27-30. (In Russ.)
24. Barakate MS, Hemli JM, Hugshes CF, et al. Coronary artery bypass grafting (CABG) after initially successful percutaneous transbuminal coronary angioplasty (PTCA): a review of 17 years experience. Eur. J. Cardiothoracic Surg. 2003; 23: 179-186.
25. Salomon NW, Page US, Bigelow JC, et al. Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J. Thorac. Cardiovasc. Surg. 1990; 100: 250-260.
26. Verheul HA, Moulijn AC, Hondema S, Schouwink M, Dunning AJ. Late results of 200 repeat coronary bypass operations. Ann. J. Cardiol. 1991; 67: 24-30.
27. Jones EL, Craver JM, Guyton RA, Bone DK, Hatcher CR. Jr Riechwald N. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol. 1983; 51(1): 7-12.
28. Lawrie GM, Morris GC, Jr Silvers A, Wagner WF, et al. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation. 1982; 66(4): 717-23.
29. Saatvedt K, Dragsund M, Nordstrand K. Transmyocardial laser revascularization and coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg. 1996; 62(1): 323-4.
30. Schaff HV, Gersh BJ, Pluth JR. Danielson GK, et al. Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. Circulation. 1983; 68(3 Pt 2): II200-4.
31. Bokeria LA, Berishvili II, Buziashvili YuI, et al. Transmyocardial laser revascularization in combination with coronary artery bypass grafting in the treatment of patients with coronary heart disease. Thoracic and cardiovascular surgery. 2001; 2: 17-24. (In Russ.)
32. Bokeria LA, Berishvili II, Buziashvili YuI, Sigaev IYu. Transmyocardial laser revascularization. M.: Institution NMIC SSH named after A.N.Bakulev, 2001. (In Russ.)
33. Bokeria LA, Panchenko VYa., Berishvili II, et al. Transmyocardial laser revascularization: experience of 230 operations. Pacific Medical Journal. 2003; 1(11): 5-10. (In Russ.)
34. Sakakibara Y, Tambara K, Sakaguchi G, Lu F, et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur. J. Cardiothorac. Surg. 2003; 24(1): 105-11; discussion 112.
35. Shevchenko YL, Gudymovich VG. Implantation of Embryonic Cardiomyocytes in a Post-Infarction Myocardium: A Long-Term Outcome after 25 Years of Follow-Up. Arch Clin Med Case Rep. 2023; 7(2): 114-119. doi: 10.26502/acmcr.96550583.
36. Shevchenko YuL, Borshchev GG, Ulbashev DS. Surgical technique of angiogenesis stimulation (extracardial myocardial revascularization) in patients with coronary artery disease. Cardiology and Cardiovascular Medicine. 2022; 6: 529-535.
37. Yamamoto N, Kohmoto T, Gu A, et al. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J. Am. Coll. Cardiol. 1998; 31: 1426-1433.
38. Rahimtoola SH. Concept and evaluation of hibernating myocardium. Annu Rev Med. 1999; 50: 75-86.
39. Heyndrickx GR, Millard RW, McRitchie RJ, et al. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J.Clin. Invest. 1975; 56: 978-985.
40. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982; 66(6): 1146-9.
41. Bolli R. Why myocardial stunning is clinically important? Basic Res. Cardiol. 1998; 93: 169-72.
42. Vahromeeva MN. Otbor bol’nyh i ocenka rezul’tatov transmiokardial’noj lazernoj revaskulyarizacii s pomoshch’yu metodov yadernoj mediciny. [dissertation] Moskva; 2003. (In Russ.)
43. Bourdillon PD, Broderick TM, Sawada SG, et al. Redional wall motion index for infarct and non- infarct regions after reperfusion in acute myocardial infarction: comparison with global wall motion index. J. Am. Soc. Echocardiogr. 1989; 2: 398-408.
44. Du Toit J, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ. Res. 1992; 70: 960-967.
45. Hearse J.D. Myocardial ischemia: can we agree on a definition for the 21st century? Cardiovascular Res. 1994; 28: 1737-1744.
46. Kloner RA, Allen J, Cox TA, et al. Stunning left ventricular myocardium after exercise tredmill testing in coronary artery desiase. Am. J. Cardiol. 1991; 68: 329-334.
47. Perez NG, Gao WD, Marban E. Novel myofilament Ca2+- sensitizing property of xanthine oxidase inhibitors. Circ. Res. 1998; 83: 423-430.
48. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000; 190(3): 255-266. doi: 10.1002/(SICI)1096-9896(200002)190:3<255.
49. Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg. 1999; 68(5): 1905-1912. doi: 10.1016/s0003-4975(99)01073-5.
50. Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation. 1973; 47(2): 276-86.
51. Horn HR, Teichholz LE, Cohn PF, Herman MV, Gorlin R. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine. The epinephrine ventriculogram. Circulation. 1974; 49(6): 1063-71.
52. Diamond GA, Forrester JS, deLuz PL, Wyatt HL, Swan HJ. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J. 1978; 95(2): 204-9.
53. Rahimtoola SH. Coronary bypass surgery for unstable angina. Circulation. 1984; 69(4): 842-848.
54. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985; 72(6): 123-35.
55. Haas F, Augustin N, Holper K, et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol. 2000; 36(6): 1927-1934. doi: 10.1016/s0735-1097(00)00968-2.
56. Bax JJ, Visser FC, Poldermans D, et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 2001; 104(12 Suppl 1): I314-I318. doi: 10.1161/hc37t1.094853.
57. Shah BN, Senior R. Role of viability imaging in the post-STICH era. Curr Opin Cardiol. 2014; 29(2): 145-151. doi:10.1097/HCO.0000000000000047.
58. Carson P, Wertheimer J, Miller A, et al. The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. JACC Heart Fail. 2013; 1(5): 400-408. doi: 10.1016/j.jchf.2013.04.012.
59. Opie LH. The ever expanding spectrum of ischemic left ventricular dysfunction. Cardiovasc Drugs Ther. 1994; 8(2): 297-304.
